被遗忘的循环:高血压大鼠中降低的中腔静脉容量通过减少交感活动来改善
Tonja W Emans1, Davi J A Moraes2, Alona Ben-Tal1,3
1Manaaki Manawa - The Centre for Heart Research, Department of Physiology, Faculty of Medical and Health Sciences, University of Auckland, New Zealand (T.W.E., A.B.-T., C.J.B., J.F.R.P., F.D.M.).
Hypertension (Dallas, Tex. : 1979)
|February 21, 2024
概括
在自发高血压的老鼠中,中腔静脉中交感神经活动增加会提高血压,并降低静脉缓冲血液体积的能力. 这表明,将交感驱动器向介质静脉可以治疗高血压.
科学领域:
- 心血管生理学心血管生理学
- 高血压研究 高血压研究
- 自主神经系统的调节规则
背景情况:
- 中腔静脉储对于血液体积和血压调节至关重要,并由交感神经内置.
- 在中腔静脉中,特别是高血压期间,对交感调节的确切作用尚未完全理解.
研究的目的:
- 在自发高血压 (SH) 的老鼠中研究对中腔静脉的交感驱动.
- 为了确定是否升高的交感驱动增加了平均循环填充压力 (MCFP) 并损害了SH大鼠中介管容量.
主要方法:
- 同时测量动脉压,中枢静脉压和中腹腔血流在有意识的Wistar和SH大鼠中.
- 使用耳内气球评估MCFP和测量血液动力学响应体积变化之前和之后的关节阻塞和带体皮化.
- 在现场测量同情静脉缩活性.
主要成果:
- 与Wistar大鼠相比,SH大鼠在体内表现出更高的MCFP和在位交感静脉缩驱动.
- 在SH大鼠中,MCFP在结节阻塞和心动脉体缩后显著下降.
- 在SH大鼠中,中腔静脉显示体积缓冲受损,体积输注期间血液流出,与Wistar大鼠不同,Wistar大鼠显示流入;这在阻塞和脱皮后正常化.
结论:
- 在SH大鼠中过度的交感静脉收缩会提高MCFP,并降低静脉容量,阻碍体积缓冲.
- 减少对中腔静脉的交感驱动可能是管理高血压的新治疗策略.
相关概念视频
Disorders of the Autonomic Nervous System
638
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
638
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Neural Regulation of Blood Pressure
2.8K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
2.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
638
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
638
Antihypertensive Drugs: Vasodilators
524
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
524


